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Abstract
Background: Olfactomedin-1 (Olfm1; also known as Noelin or Pancortin) is a highly-expressed secreted brain and
retina protein and its four isoforms have different roles in nervous system development and function. Structural
studies showed that the long Olfm1 isoform BMZ forms a disulfide-linked tetramer with a V-shaped architecture.
The tips of the Olfm1 “V” each consist of two C-terminal β-propeller domains that enclose a calcium binding site.
Functional characterisation of Olfm1 may be aided by new biochemical tools derived from these core structural
elements.
Results: Here we present the production, purification and structural analysis of three novel monomeric, dimeric
and tetrameric forms of mammalian Olfm1 for functional studies. We characterise these constructs structurally by
high-resolution X-ray crystallography and small-angle X-ray scattering. The crystal structure of the Olfm1 β-propeller
domain (to 1.25 Å) represents the highest-resolution structure of an olfactomedin family member to date, revealing
features such as a hydrophilic tunnel containing water molecules running into the core of the domain where the
calcium binding site resides. The shorter Olfactomedin-1 isoform BMY is a disulfide-linked tetramer with a shape
similar to the corresponding region in the longer BMZ isoform.
Conclusions: These recombinantly-expressed protein tools should assist future studies, for example of biophysical,
electrophysiological or morphological nature, to help elucidate the functions of Olfm1 in the mature mammalian
brain. The control over the oligomeric state of Olfm1 provides a firm basis to better understand the role of Olfm1 in
the (trans-synaptic) tethering or avidity-mediated clustering of synaptic receptors such as post-synaptic AMPA
receptors and pre-synaptic amyloid precursor protein. In addition, the variation in domain composition of these
protein tools provides a means to dissect the Olfm1 regions important for receptor binding.
Keywords: Nervous system, Signalling, Synapse, Protein purification, X-ray crystallography, Small-angle X-ray
scattering
Background
Olfactomedin family proteins play important roles in ner-
vous system function and development throughout the
animal kingdom [1, 2]. The prototypical member Olfm1 is
a secreted glycoprotein expressed at high levels in the
brain [3, 4]. As a result of alternative promotor usage and
splicing, Olfm1 exists in four isoforms [5], referred to as
AMY, BMY, AMZ and BMZ. The letters A, B, M, Y and Z
refer to the different exons in each isoform in correspond-
ing sequential order from N- to C-terminus (Fig. 1). These
isoforms are differentially expressed in discrete brain re-
gions and over the course of development [5].
The four isoforms share the M exon, which contains
a central tetramerisation domain (denoted N-terminal
tetramerisation, NTT) [6] that has not been structurally
characterised. Otherwise the isoforms differ at the N-
and C-termini. The A isoforms have an alternative sig-
nal peptide but no unique residues in the mature
protein and represent a truncation at the N-terminus of
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a contiguous stretch of 34 residues compared to the B
isoforms. C-terminal of the NTT is a parallel dimeric
coiled-coil segment. Y isoforms end with a single gly-
cine residue (Gly153) at the C-terminus of this coiled
coil segment (Fig. 1). The longer Z isoforms on the
other hand have a more extended coiled coil (69 resi-
dues longer), followed by a highly conserved β-
propeller domain (residues 226–478) at the C-terminus
that represents more than half the protein mass (Fig. 1).
These Z isoforms are substantially more abundant in
the brain than the shorter Y isoforms [7, 8]. The β-
propellers in the Z isoforms are covalently dimerised by
an inter-chain disulfide bond (formed by Cys221-
Cys221) at the C-terminus of the preceding coiled-coil
domain [6]. It is likely that all four isoforms of Olfm1
form disulfide-linked tetramers by disulfide bonds in
the NTT domain that they have in common and that
this tetrameric nature is important for the function of
Olfm1, for example by allowing Olfm1 to cluster mul-
tiple cell-surface receptors.
Although the exact functions of Olfm1 in the brain are
not understood at the mechanistic level, several studies
have found roles for Olfm1 in nervous system develop-
ment of different vertebrates. Olfm1 was found to stimu-
late neurogenesis [9], play a role in neural crest generation
[10] and stimulate axonal elongation [11]. However, ex-
pression of Olfm1 still increases strongly from embryonic
and juvenile stages into adulthood in mice [7, 12], suggest-
ing Olfm1 additionally functions in the adult brain beyond
its developmental roles.
Olfm1 has been reported to interact with various
nervous system cell surface receptors such as Amyloid
Precursor Protein (APP) [13], the Nogo Receptor [14],
and glutamate-gated ion channels of the α-amino-3-
Fig. 1 Purification of three novel Olfm1 constructs; Olfm1Olf, Olfm1coil-Olf and Olfm1BMY. a Overview of Olfm1 sequence and isoform differences.
Indicated domain widths scale with amino acid sequence length. N-linked glycosylation sites and cysteines are indicated. b Architecture of
tetrameric Olfm1BMZ (full-length) isoform as previously determined [6]. Colours correspond to domains as indicated in panel a. c Coomassie-
stained SDS-PAGE analysis of purified Olfm1Olf, Olfm1coil-Olf and Olfm1BMY shows a high degree of purity and confirms correct formation of
disulfides in Olfm1coil-Olf and Olfm1BMY as evidenced by the shift under non-reducing (−DTT) conditions. The multiple bands predominantly
visible in the reduced samples, with apparent weight differences of a few kDa, are the result of heterogeneous N-linked glycosylation (Fig. 2)
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hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) re-
ceptor family GluA1–4 [8, 15–24]. In recent years it was
found that Olfm1 is enriched in synapses [8, 22] and
proximity labelling identified its presence in the synaptic
cleft [25, 26]. Taken together the findings that Olfm1 is
secreted [4, 9, 10], interacts with synaptic cell surface
receptors, is enriched in the synapse and is present in
the synaptic cleft suggest that Olfm1 plays a role in this
intercellular substructure.
In line with this hypothesis, a mutation that results in
deletion of 52 residues in the coiled coil region of Olfm1
leads to brain dystrophy, altered interaction with synap-
tic components and aberrant calcium signalling and be-
haviour in mice [18], as well as functional deficits of the
eye [27]. A full knockout of Olfm1 in zebrafish showed
impaired AMPA receptor trafficking and reduced levels
of pre- and post-synaptic proteins such as VAMP-2 and
GluA2 [22]. Finally, a recent study showed that Olfm1
decreases surface mobility of synaptic AMPA receptors
[8], directly linking Olfm1 to controlling synaptic plasti-
city [28]. However, the exact role and the mechanisms
by which Olfm1 exerts those functions are yet to be
determined.
In recent years, structures of the Olf domain of a
number of olfactomedin family members have been de-
termined, such as those of gliomedin, myocilin,
latrophilin-3 and Olfm1 itself [6, 29–36]. Although pro-
gress has been made towards elucidating the functions
of Olfm1 in the (mature) brain, studies are hampered
by a lack of molecular tools to dissect Olfm1 interac-
tions at the mechanistic level. Here we describe new re-
combinant Olfm1 constructs and purification strategies
to obtain pure monomeric, dimeric and tetrameric vari-
ants of mammalian Olfm1 that can be used for func-
tional studies. We characterise the structures of these
constructs by high-resolution X-ray crystallography and
small-angle X-ray scattering (SAXS). The structural
data indicate the samples are of high quality and suit-
able as molecular probes to study Olfm1 function.
Moreover, our structures reveal new insights such as a
hydrophilic tunnel containing water molecules running
into the hydrophobic core of the C-terminal β-
propeller domain, that connects to the sodium and cal-
cium binding sites. We also confirm that, similar to
other Olf family members [29–35], the bound Na+ and
Ca2+ ions stabilise a surface loop at the top face of the
β-propeller. Finally, we show that the shorter BMY iso-
form forms disulfide-linked tetramers, consistent with
the architecture of the longer BMZ isoform [6].
Materials and methods
Constructs
All constructs were obtained via polymerase chain reac-
tion using Mus musculus (mouse) Olfm1 BMZ isoform
(NCBI Reference Sequence NP_062371) cDNA
IRAVp968C0174D (Source Bioscience) as a template.
They were subsequently subcloned using BamHI and NotI
restriction sites into the pUPE107.03 (U-Protein Express)
mammalian expression vector containing an Epstein-Barr
virus origin of replication, a C-terminal His6-tag and a
cystatin signal peptide for secretion. Residues (UNIPROT
numbering) 226–478 (Olfm1Olf), 212–478 (Olfm1coil-Olf)
or 17–153 (Olfm1BMY; residue 153 being a glycine as in
native BMY), are flanked by an N-terminal GS- and a C-
terminal -AAAHHHHHH sequence in the mature protein
as a result of the restriction sites and affinity tag. The C-
terminal -VIRSDEL residues have not been included in
the Olfm1Olf and Olfm1coil-Olf constructs as removal en-
hanced expression and secretion levels.
Protein expression and purification
Constructs were transiently transfected with polyethyle-
nimine in suspension culture growing N-acetylglucosa-
minyltransferase I-deficient (GntI−/−) Epstein-Barr virus
nuclear antigen I-expressing HEK293 cells (U-Protein
Express) in Freestyle™ medium, following established
protocols [37]. After 6 days, cell supernatant was har-
vested by centrifugation at 1000×g for 15 min and
filtered through a 0.22 μm filter. The filtered supernatant
was concentrated fivefold and buffer exchanged to 500
mM NaCl, 5 mM CaCl2, 25 mM HEPES pH 7.8, (IMAC
A buffer) using a 10 kDa molecular weight cut-off
(MWCO) membrane. Protein was purified by nickel-
nitrilotriacetic acid affinity chromatography, using a pre-
packed Histrap column (GE Healthcare). For Olfm1Olf,
the column was washed with 20 column volumes of
IMAC A supplemented with 40 mM imidazole and
eluted with IMAC A supplemented with 200 mM imid-
azole (pH adjusted to pH 7.8 after adding imidazole).
Due to their predicted oligomeric nature, washing and
elution were performed with higher concentrations of
imidazole for Olfm1coil-Olf and Olfm1BMY; washing with
IMAC A supplemented with 50 mM imidazole (for 20
column volumes) and eluting with 500 mM imidazole in
IMAC A.
The eluate was concentrated using 10 kDa MWCO
centrifugal filter units (Amicon®). Subsequent purifica-
tion was performed by size exclusion chromatography
(SEC) on a Superdex75 Hiload 16/60 column (for Olf-
m1Olf) or a Superdex200 Hiload 16/60 column (for
Olfm1coil-Olf and Olfm1BMY) (GE Healthcare), equili-
brated in SEC buffer (150mM NaCl, 2 mM CaCl2, 20
mM HEPES, pH 7.5). Protein purity, covalent oligomeric
state and glycosylation state were assessed by SDS-
PAGE (Figs. 1 and 2).
For Olfm1coil-Olf, peak fractions containing only
disulfide-linked dimer according to non-reducing SDS-
PAGE were pooled. Fractions containing disulfide-linked
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dimer contaminated with monomer were subjected to a
second step of SEC on the same column, allowing more
correctly folded disulfide-linked dimer to be recovered
(Figs. 1c and 3b). Protein was concentrated to 14.3 mg/
mL (Olfm1Olf) or 6 mg/mL (Olfm1coil-Olf and Olfm1BMY)
using 10 kDa MWCO centrifugal filter units (Amicon®)
before aliquoting and plunge-freezing in liquid nitrogen.
Deglycosylation
To test whether the observed heterogeneity (multiplets)
on reducing SDS-PAGE (Fig. 1c) was caused by hetero-
geneous glycosylation, we performed deglycosylation
with Endo-Hf (New England Biolabs) under denaturing
conditions. Samples were heated to 368 K for 10 min in
denaturing buffer (provided with the enzyme) before let-
ting them cool down to 298 K and adding Endo-Hf at a
ratio of 1:10 (v/v). The reaction was incubated overnight
at 298 K, before performing SDS-PAGE under reducing
conditions together with untreated sample at the same
concentration (Fig. 2).
SEC-MALS
Size-exclusion chromatography with multi-angle light
scattering (SEC-MALS) was performed at room
temperature using an analytical Superdex200 Increase
10/300 column (GE Healthcare) equilibrated with SEC
buffer. SEC was performed with online static light scat-
tering (miniDAWN TREOS, Wyatt Technology) and dif-
ferential refractive index (dRI, Shimadzu RID-10A) on a
Shimadzu HPLC system equipped with a temperature-
controlled autosampler (SIL-20 AC, at 277 K) and col-
umn oven (CTO-20 AC; at 293 K), at a flowrate of 0.5
mL/min. Data were analysed using the ASTRA software
suite (Wyatt Technology). The dRI signal was combined
with the light scattering to determine the molecular
mass using standard protocols. A dn/dc of 0.178 mL/g
was used for Olfm1Olf, and of 0.180 mL/g for Olfm1coi-
l-Olf and Olfm1BMY, based on the number of N-linked
glycans. Rabbit Aldolase was injected at 1 mg/mL as a
control and calibration standard (for Aldolase a dn/dc of
0.186 mL/g was used).
Crystallisation and structure determination
Prior to crystallization, samples of Olfm1Olf and Olfm1-
coil-Olf were deglycosylated by treatment with
Endoglycosidase-H (Endo-H), added at a 1:100 (v/v) ra-
tio and incubating at 37 °C overnight. Crystallization was
performed using the sitting drop vapour diffusion
method, mixing 150 nL protein sample with 150 nL res-
ervoir solution, at 293 K for Olfm1Olf and at 277 K for
Olfm1coil-Olf.
Crystals grew in a condition containing 8% (w/v) PEG
8000 and 0.1 M Tris-HCl pH 8.5 for Olfm1Olf and 0.08
M Magnesium Acetate, 30% (w/v) PEG 4000 and 0.05M
Sodium Cacodylate pH 6.5 for Olfm1coil-Olf. Crystals
were cryo-protected with reservoir solution supple-
mented with 25% (v/v) glycerol before plunge-cooling in
liquid nitrogen. Datasets were collected at 100 K at
European Synchrotron Radiation Facility (ESRF) beam-
line ID30A-3 (Massif-3) for Olfm1Olf or Diamond Light
Source (DLS) beamline I03 for Olfm1coil-Olf. Grid scan-
ning was used for the Olfm1Olf crystals to find the best-
diffracting sub-volume of each crystal.
Data were integrated and scaled by XDS [38] and
merged and truncated by the Aimless pipeline [39], re-
spectively. Structures were solved by molecular replace-
ment with PDB 5AMO [6] as a search model using
Phaser [40]. Iterative cycles of manual model building in
Coot [41] and reciprocal space refinement with Phenix
[42] were performed for final refinement. Cα RMSDs
were calculated by secondary structure matching using
the program superpose [43].
Fig. 2 Glycosylation of Olfm1Olf, Olfm1coil-Olf and Olfm1BMY is
heterogeneous. Band multiplets visual in reduced SDS-PAGE are the
result of heterogeneous glycosylation. Deglycosylation of Olfm1Olf,
Olfm1coil-Olf and Olfm1BMY by Endo-Hf under denaturing condition
reduces the heterogeneity; the multiplets, visible in the untreated
samples, disappear and a prominent single band of lower molecular
mass remains
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Small-angle X-ray scattering
SAXS was performed at the ESRF BM29 BioSAXS
beamline equipped with a 2D Pilatus 1M detector
(DECTRIS, Switzerland) operated at an energy of 12.5
keV. Olfm1BMY was diluted with and dialysed against
SEC buffer using a 10 kDa MWCO membrane. The con-
centration of Olfm1BMY was determined by UV spectro-
photometry at 280 nm wavelength on a nanodrop ND-
1000 spectrophotometer to be 0.615 mg/mL. SAXS data
were collected at 277 K. Ten successive 1.0 s frames were
collected. The data were radially averaged and normal-
ised to the intensity of the transmitted beam, exposure
time, and sample concentration, and the scattering of
the solvent blank (SEC buffer) was subtracted. The curve
was scaled to absolute values using a water reference so
that the I0 represents the Olfm1 molecular weight. Radi-
ation damage was monitored by comparing curves col-
lected on the same sample; no evidence for radiation
damage was observed. Data were analysed by the Atsas
suite [44] programs Primus [45] for the Guinier analysis,
Gnom [46] for the pair-distance distribution function
and Dammif [47] for the ab-initio modelling.
Results
We produced monomeric, dimeric and tetrameric vari-
ants of Mus musculus (mouse) Olfm1 in mammalian
cells. The monomeric construct comprises the C-
terminal Olfactomedin domain (henceforth referred to
as Olfm1Olf) (Fig. 1a). The dimeric construct is com-
posed of the Olfactomedin domain and additionally in-
cludes part of the coiled coil and the inter-chain
disulfide formed by Cys221 at the N-terminus of the Olf
domain, similar to our previously crystallised limited
proteolysis fragment (Olfm1coil-Olf) [6] (Fig. 1a). The
third construct corresponds to the natural isoform BMY
(Olfm1BMY) and therefore lacks the C-terminal half of
the coiled coil and the Olfactomedin domains (Fig. 1a),
but does include the NTT domain and is thus expected
to be tetrameric like the full-length BMZ isoform [6].
Fig. 3 Preparative and analytical SEC profiles of the three Olfm1 constructs confirm their predicted oligomeric state a SEC chromatogram of
Olfm1Olf on a HiLoad 16/60 Superdex75 column. b SEC chromatogram of Olfm1coil-Olf on a HiLoad 16/60 Superdex200 column, corresponding to
the second injection (see Materials and methods section for details). c SEC chromatogram of Olfm1BMY on a HiLoad 16/60 Superdex200 column.
An accolade indicates the pooled fractions for all three preparative chromatograms. d Analytical SEC-MALS analysis on a Superdex200 10/300
increase column of Olfm1Olf, Olfm1coil-Olf and Olfm1BMY confirms their predicted respective monomeric, dimer and tetrameric states (colours
corresponding to panels a, b and c, respectively). The standard, aldolase (158 kDa), is shown in yellow and was used to calibrate the MALS signal
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All constructs were purified from the supernatant of
over-expressing HEK293 GntI−/− cells by a combination
of Ni2+-affinity chromatography and SEC (Figs. 1c and 3).
Care was taken to always include calcium chloride in the
purification buffers as we previously observed this pro-
foundly stabilises full-length Olfm1BMZ [6]. Higher con-
centrations of imidazole were used for washing and
eluting the dimeric Olfm1coil-Olf and tetrameric Olfm1BMY
than for the monomeric Olfm1Olf (see Materials and
methods section for details) as they are expected to have
two and four tags per molecule, respectively. We would
like to remark that the inclusion of calcium chloride in
buffers and the washing and elution with higher concen-
trations of imidazole (50 instead of 40mM for washing
and 500 instead of 200mM for elution) also improve the
yield and purity of tetrameric Olfm1BMZ (data not shown)
compared to our previously-published tetrameric
Olfm1BMZ purification strategy [6]. Predicted oligomeric
state of the three constructs was confirmed by analytical
SEC-MALS (Fig. 3d), revealing molecular masses of 36 ±
1 kDa for Olfm1Olf (35 kDa is predicted for a monomer in-
cluding 4 N-linked glycans), 73 ± 1 kDa for Olfm1coil-Olf
(73 kDa is predicted for a dimer including 8 N-linked gly-
cans) and 77 ± 4 kDa for Olfm1BMY (77 kDa is predicted
for a tetramer including 8 N-linked glycans).
Monomeric Olfm1Olf
Based on our previous structure [6], we designed trun-
cations that are expected to result in a monomeric do-
main by truncating the dimerizing coiled coil and
excluding Cys221 from the construct (Fig. 1, the Olf-
m1Olf construct includes UNIPROT residues 226–478).
This construct expressed with high yields in HEK293
cells (about 30 mg from a litre of HEK293 suspension
cell culture) and could be purified using standard pro-
tocols (see Materials and methods section for details).
We determined a high-resolution crystal structure of
Endo-H-deglycosylated Olfm1Olf (Fig. 4), which leaves a
single acetylglucosamine (GlcNAc) attached to glycosyl-
ated asparagines. The deglycosylation step often aids
crystallisation. Our best crystal diffracted to 1.25 Å reso-
lution (Table 1), representing the highest resolution
crystal structure of an Olfactomedin domain to date.
The highly conserved monomeric Olf domain has a five-
bladed β-propeller fold with a central metal ion binding
site [29–34, 50]. The structure shows a high degree of
similarity to the Olf-domain dimer in our previously-
determined structure of a dimeric Olfm1coil-Olf (PDB
5AMO) [6] (Cα RMSD of 0.55 Å, Fig. 5). A human
Olfm1 Olf domain structure derived from bacterially-
expressed protein [35] has a very similar structure to our
mouse Olfm1Olf (Cα RMSD of 0.44 Å, Fig. 6), other than
it lacking N-linked glycosylation as a result of the ex-
pression system. Comparing the structures of mouse
Olfm1Olf and human Olfm1Olf [35] with that of Olfm1-
coil-Olf, reveals structural rearrangements arising from
the coordination of the Ca2+ and Na+ ions, that are not
present in our previously determined structure of
Olfm1coil-Olf [6].
Because of the high resolution of our Olfm1Olf diffrac-
tion data to 1.25 Å, we can unambiguously assign a Na+
and a Ca2+ ion bound in the central cavity of the β-
propeller. Metal ion assignment was based on previous
binding data [6, 35], coordination distances (Table 2)
[51] and fit to the electron density. The Ca2+ ion is coor-
dinated by the negatively-charged carboxyl groups of the
side chains of Asp356, Asp453 and Glu404, as well as by
the backbone carbonyl groups of Ala405 and Leu452
and a single water molecule (Fig. 4b and Table 2 for co-
ordination distances and angles). The Na+ ion is also co-
ordinated by the carboxylic acid groups of the side
chains of both Asp356 and Asp453, as well as by the
backbone carbonyl group of Leu357 and a different
water molecule than the one coordinating the calcium
ion (Fig. 4b, Table 2). In sum, three formal negative
charges of the carboxylic acid groups of the side chains
of Asp356, Asp453 and Glu404 are compensated by
three formal positive charges of the bound Ca2+ and Na+
ions.
Two non-bonding interactions appear to be formed
between the backbone carbonyl groups of Gly302 and
Gln303 with the Na+ ion that are at distances too great
for direct coordination (2.9 and 3.0 Å, respectively) [52].
Furthermore, several of the coordination angles deviate
substantially from 90 ° that may be expected for octahe-
dral metal ion coordination and range from 81.4 to
105.5 ° for the Ca2+ ion and from 66.6 to 109.4 ° for the
Na+ ion (Table 2). Still, the coordination of both Ca2+
and Na+ ions most closely resembles octahedral geom-
etry (including the two non-bonding interactions with
the backbone carbonyls of Gly302 and Gln303), rather
than trigonal bipyramid, tetrahedral, square planar or
square pyramid. Coordination distances range from 2.3
to 2.4 Å for the Ca2+ ion and from 2.2 to 2.4 Å for the
Na+ ion, excluding the non-bonding interactions with
the backbone carbonyls of Gly302 and Gln303. This is
close to the ideal distances of 2.3 to 2.4 Å for the Ca2+
ion and of 2.3 to 2.5 Å for the Na+ ion [51].
A loop connecting propeller blade 2 to blade 3 (resi-
dues 339–352, sequence AGYNNMYHYAWGGH) that
was unstructured in our previously-determined structure
of Olfm1coil-Olf (PDB 5AMO) [6] could now be fully ob-
served in the electron density (Figs. 4 and 5), possibly as
a result of a structural transition induced by Na+ and
Ca2+ binding. Because of this structural transition, we
will henceforward refer to this loop as the switch loop.
The conserved residue Tyr347 stabilises the switch loop
by forming a hydrogen bond between the Tyr347
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hydroxyl group and the Asp356 carboxyl group (distance
2.7 Å) that plays a central role in coordinating both the
bound sodium and calcium ions (Figs. 4 and 5). The
Asp356 side chain adopts a different rotamer conform-
ation and is pushed outward in the calcium-free struc-
ture [6]. Most likely this outward conformation arises
from electrostatic repulsion by the other negatively-
charged metal ion coordinating side chains, Glu404 and
Asp453, that are no longer compensated by the positive
charges of the Ca2+ and Na+ ions in the apo form. The
outward Asp356 conformation in the apo form disrupts
the hydrogen bond with Tyr347 and interferes with the
conformation of the switch loop as observed in the
Ca2+- and Na+-bound state by steric hindrance with
Tyr347 (Fig. 5), possibly resulting in the switch loop be-
ing unstructured in the apo form.
The high-resolution crystal structure of Olfm1Olf re-
veals a hydrophilic tunnel filled with water molecules
running from the surface of the Olf domain to the
metal ion binding sites (Fig. 4a and c). A similar
water-containing tunnel was observed in the structure
of the gliomedin Olf domain [29]. In Olfm1, the tun-
nel starts at the solvent-exposed top face between
propeller blade 2 and 3 and runs between these two
blades towards the metal ion binding sites. The tun-
nel proceeds further, almost to the bottom of the do-
main where it is closed by a hydrophobic plug made
up of residues Pro253 in blade 1, Val359 in blade 3
and Pro456 in blade 5 (Fig. 4a). Twelve ordered water
molecules are well resolved in this tunnel due to the
high resolution of our electron density map, including
the two water molecules involved in coordinating the
Na+ and Ca2+ ions. The width of the tunnel varies
along the pore axis with radii of 1.0 to 2.2 Å, as de-
termined by the HOLE program [48] (Fig. 4a and c).
These tunnel dimensions are too small to allow the
passage of hydrated ions. The tunnel may, however,
allow dehydrated metal ions, coordinated by tunnel-
lining residues, to pass through this pore in the pres-
ence of thermal motion at physiological temperatures.
Previous work showed that excess calcium stabilises
folded purified Olfm1 [6, 35], whereas EDTA (a Ca2+
chelator) destabilises it [6]. In addition, sequestering
of Ca2+ from the propeller domains by the excess of
EDTA may increase the flexibility of the switch loop.
This implies that calcium ions can dissociate from
the folded protein, presumably by diffusion out of the
β-propeller domain via the central tunnel.
Fig. 4 High-resolution crystal structure of Olfm1Olf to 1.25 Å with bound Na+ and Ca2+ ions reveals a structured switch loop and a water tunnel
running to the metal ion binding sites. a Overview of the Olfm1Olf β-propeller domain with the bound Na+ (purple) and Ca2+ (green) ions. The
switch loop is indicated in violet, the water tunnel in green, the hydrophobic plug residues closing the tunnel in dark red and individual water
molecules in the tunnel are represented as red spheres. The intra-chain disulfide between Cys227 and Cys409 is shown in sticks representation. b
Close-up of the metal ion binding site with 2Fo-Fc electron density contoured at 2.5 σ. Metal ion-coordinating interactions are shown as black
dashes and the hydrogen bond of the coordinating carboxylic acid group of Asp356 with the hydroxyl group of Tyr347 in the switch loop is
indicated in green. c Analysis of the tunnel radius by HOLE [48]
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Dimeric Olfm1coil-Olf
A dimeric variant containing part of the coiled coil and
Olf domain, corresponding to our previously crystallised
proteolysis fragment, was designed with domain bound-
aries 212–478 (UNIPROT numbering, Fig. 1). This in-
cludes Cys221 that forms an inter-chain disulfide and
covalently locks this construct in a dimeric form. The
better-defined domain boundaries of this construct,
compared to our previously described proteolysis frag-
ment [6], provides more control over the quality of this
sample. Only about a third of this recombinant Olfm1coi-
l-Olf sample formed disulfide-linked dimers as in the
crystal structure, yet the monomeric and dimeric frac-
tions could be separated from each other by two rounds
of SEC (Figs. 1c and 3b, see Materials and methods sec-
tion for details). Attempts to rescue the remaining
monomeric fraction by reducing the disulfides and
refolding in the presence of a redox couple were unsuc-
cessful. The yields of dimeric Olfm1coil-Olf are about 2
mg per litre of suspension HEK293 cell culture.
We crystallised the dimeric form of Olfm1coil-Olf, after
deglycosylation with Endo-H, with calcium chloride
present in the buffer (Fig. 7a). Olfm1coil-Olf crystallised in
the same crystal form (space group C2) as the
previously-determined limited proteolysis fragment cor-
responding to the same segment of Olfm1 (PDB 5AMO)
[6], in spite of several differences such as the crystallisa-
tion condition, the crystallisation temperature, the pres-
ence of bound Ca2+ and Na+ ions and the glycosylation
state. The Olfm1coil-Olf structure reported previously [6]
was not deglycosylated indicating that the glycans did
not contribute substantially to the crystal packing. The
crystals were not fully isomorphous and displayed subtle
changes in unit cell parameters. The largest differences
are in unit cell dimension b (47.0 Å in this study,
whereas 43.9 Å in 5AMO) and angle β (117.4 ° in this
study, whereas 114.2 ° in 5AMO). However, apart from
the switch loop being observed in the calcium-stabilised
conformation similar to the monomeric Olfm1Olf struc-
tures discussed above, the structures of the limited
proteolysis fragment and recombinantly-expressed
Olfm1coil-Olf were highly similar (Cα RMSD of 0.73 Å,
Fig. 7b), validating the quality of the sample.
The outward-facing β-propeller top face of the Olf do-
main has been suggested to be involved in receptor
binding [6] because of the conserved nature and the ab-
sence of N-linked glycans at this site. The switch loop
forms part of this top face in the calcium-bound state
and alters the properties of this surface. In the calcium-
bound state the top face still consists of conserved resi-
dues and is devoid of glycans (Fig. 7c and d, right panel).
By altering its conformation upon Ca2+ and Na+ binding,
the switch loop might make this putative interface con-
ditional, i.e. dependent on the presence of Ca2+ and/or
Na+, as has been observed for the olfactomedin family
member latrophilin3. Latrophilin3 binds to the cell sur-
face receptor FLRT3 in a calcium-dependent way via the
same loop [32]. Another putative region of interaction is
the crevice between the two Olf domains, flanked by β-
propeller blades 4 and 5 (Fig. 7d). This region is also
conserved, void of N-linked glycans and the conform-
ation of the switch loop is not affecting this area.
Possibly, the top face of the Olf domains represents a
Ca2+-dependent conditional interface, whereas the crev-
ice between the two Olf domains is a putative Ca2+-inde-
pendent interface for protein-protein interactions.
Table 1 Data collection and processing statistics
Data Collection
PDB ID 6QHJ (Olfm1Olf) 6QM3 (Olfm1coil-Olf)
Beamline ESRF ID30A-3 DLS I03
Resolution range (Å)a 36.76–1.25 (1.29–1.25) 75.99–1.89 (2.10–1.89)
Wavelength (Å) 0.9677 0.9762
Space Group I222 C2
Unit Cell Dimensions
a, b, c (Å) 61.79, 79.63, 111.72 160.7, 47.0, 105.0
α, β, γ 90.0, 90.0, 90.0 90.0, 117.4, 90.0
Measured reflections 416,910 95,762
Unique reflections 72,028 29,117
Mean I/σ 13.7 (1.0) 10.3 (1.7)
Completeness (%) 94.6 (63.9) 92.2 (77.2)
Redundancy 5.8 (2.4) 3.3 (3.4)
Rmerge (%) 8.4 (90.8) 6.0 (75.1)
CC1/2 0.998 (0.445) 0.998 (0.551)
Data Refinement
Resolution Range (Å) 33.75–1.25 71.30–2.00
Total reflections 72,027 28,629
Test set 3623 1459
Rwork 0.124 0.179
Rfree 0.141 0.216
No. of protein atoms 4374 4321
No. of ligand atoms 156 133
No. of water atoms 298 99
RMSD from ideal
Bonds (Å) 0.010 0.007
Angles (°) 1.168 0.852
Mean B factor (Å2) 17.25 49.09
Ramachandran
Favoured (%) 96.8 96.4
Outliers (%) 0.4 0.0
Clashscoreb 1.11 3.58
aNumbers in parentheses correspond to values for the highest resolution shell
bValue calculated by MolProbity [49]
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The Olfm1 paralogues Olfm2 and Olfm3, which share
sequence identity conservation of 56.8–67.5% with
Olfm1, have all elements responsible for a similar V-
shaped disulfide-linked tetrameric arrangement as ob-
served in Olfm1BMZ (N-terminal cysteines, central
coiled-coil domain, C-terminal cysteines and β-propeller
domains) [6]. In the β-propeller domain, most of the se-
quence variation is, as expected, in the surface-exposed
residues. The core of the protein is highly conserved and
there are no insertions or deletions in this domain. One
notable difference between these three paralogues is the
(predicted) N-linked glycosylation pattern (Fig. 7a).
Whereas the N-linked glycans on Olfm1 N307 and
N473 are conserved in both Olfm2 and Olfm3, the one
on N431 is only conserved in Olfm2 but not in Olfm3.
The N-linked glycans on N288 and N394 on the other
hand are not conserved in either Olfm2 or Olfm3. Other
than that, Olfm2 is predicted to have a unique N-linked
glycan on its β-propeller domain on N304 (UNIPROT
numbering), which corresponds to Olfm1 N342, that is
not part of an N-linked glycosylation motif. Olfm1 N342
is surface-exposed and resides in the switch loop.
Whether N304 in Olfm2 is actually glycosylated has not
been determined. As discussed in detail elsewhere [6,
35], the tertiary structure of the β-propeller domain of
Olfm1 is very similar to that of the more distant homo-
logues gliomedin, latrophilin3 and myocilin, yet the
switch loop structure and the surface charge distribution
of the β-propeller domain differ substantially.
Tetrameric Olfm1BMY
We expressed a third construct based on the natural
shorter BMY isoform (Olfm1BMY; UNIPROT residue
17–153, residue 153 being a glycine), that is expected to
form disulfide-linked tetramers as it includes the NTT
domain. Compared to the longer BMZ isoform,
Olfm1BMY lacks the C-terminal half of the coiled-coil
domain as well as the C-terminal Olf domains (Fig. 1).
This construct was expressed with reasonable yields (0.5
Fig. 5 Comparison of Olfm1Olf domain in the Ca2+- and Na+-bound state in grey with the previously-published apo state in teal [6]. The switch
loop (violet) is only resolved in the Ca2+- and Na+-bound state. In the apo state, the negatively-charged side chains of Asp356, Glu404 and
Asp453 are pushed outward in the absence of compensating positive charges from the Na+ and Ca2+ ions (indicated by arrows in the right
panel). This most likely destabilises the conformation of the switch loop (violet) via Tyr347, which consequently is unstructured (indicated by a
dashed line in the left panel) and thus not observed in the electron density of the apo form [6]. The intra-chain disulfide between Cys227 and
Cys409 is shown in stick representation
Fig. 6 Mouse Olfm1Olf and human Olfm1Olf are very similar.
Structural comparison of mouse Olfm1Olf produced in mammalian
(HEK293) cell line (grey) with human Olfm1Olf produced in a
bacterial expression system (PDB 4XAT, yellow) [35], both with
bound Na+ and Ca2+, shows a high degree of similarity (Cα RMSD of
0.44). The switch loop (violet) is stabilised by bound Ca2+ and Na+
ions in both structures
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mg per litre of suspension HEK293 cell culture), albeit
lower than the Olfm1Olf or Olfm1coil-Olf constructs. The
non-reducing gel and SEC-MALS analysis support our
prediction that this construct forms a disulfide-linked
tetramer (Figs. 1c and 3d). Interestingly, while the light
scattering by Olfm1BMY clearly shows it to be tetrameric
(determined mass of 76.8 ± 3.6 kDa from the MALS sig-
nal; expected 76.8 kDa for a tetramer), the elution vol-
ume corresponds to a much larger globular protein
(eluting at the same volume as the calibration standard
Aldolase; 158 kDa), suggesting Olfm1BMY has an
extended conformation. The observation that the tetra-
meric Olfm1BMY constructs runs as a tetramer on non-
reducing gel indicates that the three sets of cysteines in
the NTT domain (Cys73, Cys75 and Cys85; Fig. 1a),
which could form six disulfide bridges per tetramer,
form interchain disulfides across the different sets of
chains.
We did not succeed in obtaining crystals of Olfm1BMY,
possibly due to the flexible nature of this protein
segment. Therefore, we analysed the structure of
Olfm1BMY by SAXS, which provides structural informa-
tion for proteins in the solution state. The SAXS I0 sug-
gests a molecular mass of 84.0 kDa for Olfm1BMY (Fig. 8,
Table 3). This further supports Olfm1BMY forming tetra-
mers, although the value is higher than the theoretical
mass confirmed by SEC-MALS of 76.8 kDa for a tetra-
mer of Olfm1BMY including 2 predicted N-linked glycans
per chain. Guinier analysis of the SAXS data shows that
Olfm1BMY has a radius of gyration (Rg) of 5.4 nm
(Fig. 8b). The pair-distance distribution function P(r) has
an asymmetric bell shape with a maximum at 4.76 nm,
representing the most commonly occurring inter-atomic
distance in the particle (Fig. 8d). The P(r) further shows
Olfm1BMY has a maximum dimension Dmax of 16.3 nm
and a Porod volume of 248 nm3. The Kratky plot indi-
cates substantial flexibility, yet still more structure than
a random coil (Fig. 8c).
Based on our previous work on the longer BMZ iso-
form of Olfm1 [6], we expected the Olfm1BMY construct
Table 2 Distances and angles of metal ion coordination in the Olfm1Olf crystal structure
Distances: Angles:
distance (Å) angle (°)
Calcium ASP356 O(carboxylate) 2.3 ASP356 O(carboxylate) Calcium GLU404 O(carboxylate) 86.7
Calcium GLU404 O(carboxylate) 2.3 ASP356 O(carboxylate) Calcium ALA405 O(carbonyl) 93.1
Calcium ALA405 O(carbonyl) 2.3 ASP356 O(carboxylate) Calcium ASP453 O(carboxylate) 105.5
Calcium LEU452 O(carbonyl) 2.3 ASP356 O(carboxylate) Calcium H2O 94.1
Calcium ASP453 O(carboxylate) 2.3 GLU404 O(carboxylate) Calcium ALA405 O(carbonyl) 83.0
Calcium H2O 2.4 GLU404 O(carboxylate) Calcium LEU452 O(carbonyl) 83.7
GLU404 O(carboxylate) Calcium H2O 82.7
Sodium GLY302 O(carbonyl) 2.9 ALA405 O(carbonyl) Calcium LEU452 O(carbonyl) 89.2
Sodium GLN303 O(carbonyl) 3.0 ALA405 O(carbonyl) Calcium ASP453 O(carboxylate) 103.8
Sodium ASP356 O(carboxylate) 2.3 LEU452 O(carbonyl) Calcium H2O 81.4
Sodium LEU357 O(carbonyl) 2.2 LEU452 O(carbonyl) Calcium ASP453 O(carboxylate) 83.6
Sodium ASP453 O(carboxylate) 2.3 ASP453 O(carboxylate) Calcium H2O 88.4
Sodium H2O 2.4
GLY302 O(carbonyl) Sodium GLN303 O(carbonyl) 66.6
ASP356 O(carboxylate) TYR347 O(hydroxyl) 2.7 GLY302 O(carbonyl) Sodium ASP356 O(carboxylate) 88.5
GLY302 O(carbonyl) Sodium LEU357 O(carbonyl) 78.3
GLY302 O(carbonyl) Sodium H2O 98.6
GLN303 O(carbonyl) Sodium LEU357 O(carbonyl) 88.4
GLN303 O (carbonyl) Sodium ASP453 O(carboxylate) 95.8
GLN303 O (carbonyl) Sodium H2O 71.0
ASP356 O(carboxylate) Sodium LEU357 O(carbonyl) 101.4
ASP356 O(carboxylate) Sodium ASP453 O(carboxylate) 109.4
ASP356 O(carboxylate) Sodium H2O 99.9
LEU357 O(carbonyl) Sodium ASP453 O(carboxylate) 98.5
ASP453 O(carboxylate) Sodium H2O 77.8
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(that makes up the N-terminal part of the longer BMZ
isoform) to have two-fold rotational symmetry (C2). Ab-
initio modelling based on our SAXS data using the
Dammif software [47] with enforced C2 symmetry yields
models that closely mimic the shape of the Olfm1BMZ
N-terminal segment observed previously by negative
stain electron tomography (Fig. 8f and g) [6]. Thus, the
shift on non-reducing gel, the SEC-MALS analysis and
the SAXS data support the notion that this natural iso-
form folds into tetramers with the same structure as the
corresponding region within the longer BMZ isoform.
Discussion
The obtained high-resolution crystal structures of the
monomeric Olfm1Olf and dimeric Olfm1coil-Olf con-
structs in the calcium- and sodium-bound states yield
several new insights. Similar to latrophilin [32], a surface
loop of Olfactomedin-1 is stabilised by the internally-
bound Ca2+ and Na+ ions in the core of the Olf domain.
Ca2+ and Na+ ions would be able to bind the buried
binding sites in the Olf domain during folding in the
high calcium environment of the secretory pathway, also
in the absence of any tunnel. The presence of this tunnel
suggests these metal ion binding sites do not just serve a
structural function. Rather, this tunnel might allow the
Olf domain to sample the concentration of these ions in
the microenvironment of Olfm1 beyond the ER. The Olf
domain of Olfm1 could serve as a calcium sensor by
providing a conditional interface for protein-protein in-
teractions, the condition being the presence of Ca2+ at
sufficiently high concentration. Since Olfm1 was found
to be enriched in synapses and present in the synaptic
cleft, it is tempting to speculate that synaptic activity,
which causes substantial local decreases in extracellular
calcium concentration [54] as a result of the opening of
pre-synaptic voltage-gated calcium channels and post-
synaptic NMDA receptors and calcium-permeable
AMPA receptors, might be sampled by the Olf domains
of Olfm1. The ability of the Olf domain to sample cal-
cium concentration might serve to control short-term or
long-term depression at synapses or prevent excitotoxi-
city as a negative feedback sensor. Further studies are re-
quired to determine if the equilibrium and kinetic
dissociation constants (Kd and kd) for calcium binding
are in the correct concentration and time regime to
sample such physiological decreases in calcium concen-
tration, and to elucidate what (if any) protein binding
partners of Olfm1 are calcium-dependent. Interestingly,
Fig. 7 Crystal structure of dimeric recombinant Olfm1coil-Olf with bound Na+ and Ca2+ ions. a Crystal structure of Olfm1coil-Olf with bound Na+
(purple) and Ca2+ (green) and the switch loop in violet. Disulfides are indicated as spheres and N-linked glycans as brown sticks. b Comparison of
the previously-solved limited proteolysis fragment of Olfm1coil-Olf in the apo state (teal, PDB 5AMO) with the presented structure in the Na+- and
Ca2+-bound state (orange) shows a very similar structure (Cα RMSD of 0.73 Å), except for the switch loop that is structured in the Na
+- and Ca2+-
bound state (it is unstructured in the apo state). c Surface representation of Olfm1coil-Olf with the putative conditional interface formed by the
switch loop (violet). d Conservation of Olfm1 amongst vertebrate orthologues plotted on the surface using Consurf [53]. The contour of the
switch loop interface as in c is indicated with a yellow line. Both the top face of the β-propellers (indicated with an accolade in the left panel;
front view in the right panel) and the crevice between the two Olf domains (indicated with an ellipse in the bottom panel) are highly conserved
and may be interfaces for protein-protein interaction
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various trans-synaptic protein complexes have been
shown to be depending on or stabilised by calcium ions,
such as β-Neurexin-neuroligin [55, 56], β-Neurexin-
LRRTM2 [57, 58], β-Neurexin-Cerebellin1-GluD2 [59],
Cadherins [60, 61], and Latrophilin3-Flrt [32], suggesting
this might be a more general mechanism.
In this regard, another attractive hypothesis that could
be studied with our constructs would be that Olfm1 is
involved in trans-synaptic interactions. Olfm1 binds
directly to post-synaptic AMPA receptors [8] and has a
V-shaped oligomeric architecture similar to the secreted
protein Cerebellin1 [6, 59], which engages with the
AMPA receptor homologue GluD2 in the synaptic cleft
of specific synapses [59, 62, 63]. Cerebellin1 tethers
these GluD2 receptors to pre-synaptic β-Neurexin [59,
63]. AMPA receptors where recently found to be aligned
on a subsynaptic scale to pre-synaptic vesicle release
sites [64]. The similar architecture of Olfm1 and Cere-
bellin1 suggests Olfm1 might bind to AMPA receptors
in a similar manner as Cerebellin1 to GluD2 receptors.
A putative pre-synaptic anchor for Olfm1 (analogous
to β-Neurexin for Cerebellin-1) could be APP, a single-
pass transmembrane protein that is known to be associ-
ated with the pre-synaptic vesicle release machinery
[65, 66]. APP was found previously to interact directly
with Olfm1, thereby modulating the proteolytic pro-
cessing of APP by secretase enzymes [13]. The tetra-
meric nature, shape and dimensions of Olfm1BMZ
might allow it to engage multiple pre- and post-
synaptic receptors, benefitting from surface avidity
similar to for example IgGs [67]. Further research is
required to determine if Olfm1 can simultaneously
engage both pre-synaptic APP and post-synaptic AMPA
receptors. If Olfm1 does trans-synaptically tether
AMPA receptors to APP in vivo, this could potentially
have implications for Alzheimer’s disease, as mutations
affecting the proteolytic processing of APP (both in
Fig. 8 SAXS analysis indicates Olfm1BMY is an “X”-shaped tetramer. a Averaged and reference-subtracted SAXS data of Olfm1BMY at 0.615 mg/mL
plotted as Log I vs Q. b Guinier plot of the SAXS data indicates Olfm1BMY forms a tetramer (Rg of 5.4 nm and I0 corresponding to 84.0 kDa). c The
Kratky plot suggests Olfm1BMY has substantial flexibility yet is more structured than a random coil. d The pair-distance distribution function P(r)
has an asymmetric bell shape with a maximum at 4.76 nm, and a maximum diameter (Dmax) of 16.3 nm. e The fit to the data (red circles) of the
P(r) (black line) and the theoretical scattering of the ab-initio bead model by Dammif shown in panel f (green dashes) indicate a good agreement
with the data (χ2 of 3.34 for the P(r) and 1.24 for the ab-initio model). f Dammif ab-initio model of Olfm1BMY with enforced C2 symmetry reveals a
shape similar to what was predicted based on the architecture of the longer BMZ isoform [6] (see panel g). g Previously-published slice through
a negatively stained electron tomogram of Olfm1BMZ [6], with the region corresponding to Olfm1BMY indicated by a red ellipse
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APP itself and its secretases) are well-known to cause
early-onset Alzheimer’s disease [68, 69], the early phase
of which is characterised by a loss of AMPA receptors
and synaptic malfunctioning [70–72].
Conclusions
Here we present three novel constructs of Olfm1; one
monomeric (Olfm1Olf), one dimeric (Olfm1coil-Olf) and
one tetrameric (Olfm1BMY), with optimised expression
and purification strategies. We validated our expression
and purification strategies by analysing the samples by
(non)-reducing SDS-PAGE and analytical SEC-MALS.
Furthermore, we determined high-resolution crystal
structures for the monomeric and dimeric constructs,
and characterised the size and shape of the tetrameric
Olfm1BMY construct by SAXS. These constructs, in com-
bination with our previously-published tetrameric BMZ
construct [6], will allow the precise probing of interac-
tions of binding partners with specific domains of
Olfm1, and can be used in functional assays to study
Olfm1 in the (mature) mammalian brain.
The constructs and purification strategies presented
here could be used to find domain-specific and calcium-
dependent binding partners. For example, the protein
samples could be used as probes to identify novel Olfm1
interactors by proteomic screening of interaction part-
ners pulled down by Olfm1-functionalised beads from
brain lysate in the presence of either calcium or EDTA.
Both new and established interactions could be further
quantified and assigned to specific domains by direct
binding assays such as surface plasmon resonance and
isothermal titration calorimetry with the described con-
structs. These new constructs, together with our previ-
ously published tetrameric Olfm1BMZ construct, could
also be used for in vitro cell or bead clustering assays to
test if pre/post-synaptic receptor binding in trans is sup-
ported by Olfm1. Moreover, the Olfm1BMY and Olfm1-
coil-Olf constructs could be used as acute dominant
negatives by interfering with one interaction but not
linking to a third protein in functional assays, such as
electrophysiological determination of synaptic input/out-
put ratio or long-term potentiation, or morphological
characterisation of synapses and dendritic spines, for
example in combination with knockout or knockdown
animals [22]. In conclusion, there are many exciting hy-
potheses about the functions of Olfm1 in the mature
(mammalian) brain that remain to be tested, for which
our novel constructs and their associated purification
strategies might provide a starting point.
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